Charcot Neuroarthropathy in a Diabetic Patient. The Need for a Multidisciplinary Interventions

Main Article Content

Ana Fernández-Araque*
Mercedes Martínez-Delgado
Zoraida Verde-Rello
Verónica Velasco-González

Abstract

The author presents the case of a 63-year-old man who was diagnosed with type 2 diabetes 15years ago (2004) and with ulcers in both feet with 12years of clinical course (which have required hospital admissions). The patient was diagnosed with moderate Charcot neuroarthropathy in 2009 using foot X-rays, receiving no specific treatment for this condition. The ulcers had been treated with multiple healing products, with poor results, for ten years.


The author presents the implementation of a care plan called DOMINATE for wound treatment and improved metabolic control of the concomitant condition. This case illustrates how important it is that health care providers consider an urgent need to establish a multidisciplinary care plan for the treatment of patients with non-healing wounds so that these patients do not have to wait months or even years to be assessed by different specialists.

Downloads

Download data is not yet available.

Article Details

Fernández-Araque, A., Martínez-Delgado, M., Verde-Rello, Z., & Velasco-González, V. (2020). Charcot Neuroarthropathy in a Diabetic Patient. The Need for a Multidisciplinary Interventions. Global Journal of Medical and Clinical Case Reports, 7(1), 001–004. https://doi.org/10.17352/2455-5282.000078
Case Studies

Copyright (c) 2020 Araque AF, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Edmonds M, Lázaro-Martínez JL, Alfayate-García JM, Martini J, Petit JM, et al. (2017) Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial. Lancet Diabetes Endocrinol 6: 186-196. Link: https://bit.ly/395EmCd

Jordan W (1936) Neuritic manifestations in diabetes mellitus. JAMA Internal Medicine 57: 307-366. Link: https://bit.ly/395WsE8

Aschenbrenner D (2017) Diabetes Drug Receives Boxed Warning for Increased Risk of Leg and Foot Amputations. Am J Nurs 117: 22-23. Link: https://bit.ly/2UkjX6M

Lee RC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, et al. (2011) The Charcot Foot in Diabetes. J Am Podiatr Med Assoc 101: 437-446. Link: https://bit.ly/38V8iR7

Milne TE, Rogers JR, Kinnear EM, Martin HV, Lazzarini PA, et al. (2013) Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute charcot neuro-arthropathy: a systematic review. J Foot Ankle Res 6: 30. Link: https://bit.ly/2TWOuJ0

Molines-Barroso RJ, Lázaro-Martínez JL, Beneit-Montesinos JV, García-Morales E, Álvaro-Afonso FJ, et al. (2019) Predictors of Diabetic foot reulceration beneath the Hallux. J Diabetes Res 2019: 9038171. Link: https://bit.ly/2IX45Ss